Lv31
220 积分 2022-03-08 加入
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study
8个月前
已完结
Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors
8个月前
已关闭
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy
8个月前
已完结
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy
8个月前
已完结
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
9个月前
已完结
Static and Dynamic Selection Thresholds Governing the Accumulation of Information in Genetic Algorithms Using Ranked Populations
9个月前
已完结
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy
9个月前
已完结
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline
9个月前
已完结
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
10个月前
已完结
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
10个月前
已完结
皖公网安备34019202002308
